<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T06:12:33Z</responseDate>
  <request identifier="oai:figshare.com:article/34041849" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34041849</identifier>
        <datestamp>2026-10-01T09:34:21Z</datestamp>
        <setSpec>category_388</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Supplementary file 1_Molecular profiling and prognostic significance of gastric cancer subtypes based on extracellular vesicle-related characteristics.docx</dc:title>
          <dc:creator>Guangyu Ding (1974004)</dc:creator>
          <dc:creator>Chenjie Xu (135659)</dc:creator>
          <dc:creator>Xingmao Huang (18231665)</dc:creator>
          <dc:creator>Federico Maria Mongardini (25155714)</dc:creator>
          <dc:creator>Pengfei Yu (680800)</dc:creator>
          <dc:creator>Chengkang Zhu (25155717)</dc:creator>
          <dc:creator>Hongtao Wang (570131)</dc:creator>
          <dc:creator>Zequan Wu (25155720)</dc:creator>
          <dc:creator>Shengxin Fang (25155723)</dc:creator>
          <dc:creator>Xinyi Lei (10717245)</dc:creator>
          <dc:creator>Minji Xu (25155726)</dc:creator>
          <dc:creator>Salvatore Tolone (3267468)</dc:creator>
          <dc:creator>Ludovico Docimo (3267483)</dc:creator>
          <dc:creator>Li Min (356608)</dc:creator>
          <dc:creator>Ling Huang (51752)</dc:creator>
          <dc:subject>Oncology and Carcinogenesis not elsewhere classified</dc:subject>
          <dc:subject>caveolae-mediated endocytosis</dc:subject>
          <dc:subject>endocytosis</dc:subject>
          <dc:subject>extracellular vesicles</dc:subject>
          <dc:subject>gastric cancer</dc:subject>
          <dc:subject>immune checkpoint markers</dc:subject>
          <dc:subject>molecular subtypes</dc:subject>
          <dc:description>Background&lt;p&gt;Gastric cancer (GC) is a molecularly heterogeneous disease. This study aims to explore whether endocytosis pathway-associated genes and immune checkpoint-related features were linked to GC subtypes and prognosis.&lt;/p&gt;Methods&lt;p&gt;Public transcriptomic datasets from TCGA and GEO were analyzed. ssGSEA was applied to predefined endocytosis-related gene sets, and NMF was used to identify molecular subtypes. Survival, tumor microenvironment features, tumor mutation burden, microsatellite instability, and differentially expressed genes were evaluated. A three-gene prognostic model was developed and assessed through retrospective internal and external validation across public cohorts for prognostic association only.&lt;/p&gt;Results&lt;p&gt;Two endocytosis-related subtypes were identified. The Group 1 subtype showed higher pathway activity, more immunosuppressive microenvironmental features, higher expression of selected immune checkpoint-related markers, and poorer survival. The Group 2 subtype showed lower pathway activity and more favorable outcomes. A three-gene signature (NRP1, SERPINE1, and MISP3) stratified patients into higher-risk and lower-risk groups across retrospective cohorts. Higher-risk cases were associated with worse overall survival and enrichment of epithelial-mesenchymal transition- and immune evasion-related pathways. This retrospective cross-cohort validation suggests that the prognostic signal was not restricted to a single dataset, but it does not demonstrate prospective clinical validity, analytical validity, or readiness for clinical implementation.&lt;/p&gt;Conclusions&lt;p&gt;Endocytosis-related molecular patterns may be associated with distinct biological and prognostic features in GC. The identified subtypes and prognostic signature should be interpreted as exploratory, hypothesis-generating findings that warrant further prospective, functional, and assay-level validation.&lt;/p&gt;</dc:description>
          <dc:date>2026-10-01T09:34:21Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fonc.2026.1948199.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Supplementary_file_1_Molecular_profiling_and_prognostic_significance_of_gastric_cancer_subtypes_based_on_extracellular_vesicle-related_characteristics_docx/34041849</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
